A pharmaco-epidemiological study of migraine and antidepressant medications: Complete one year data from the Norwegian population

Journal of Affective Disorders

Volumn 129, Issue 1-3, 2011, Pages 198-204

  Oedegaard, Ketil Joachim ^a,b   Riise, Trond ^b   Dilsaver, Steven C ^c   Lund, Anders ^a,b   Akiskal, Hagop S ^d,e   Fasmer, Ole Bernt ^a,b   Hundal, Eøivind ^a,f  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Comprehensive Doctors Medical Group ^*  (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Apotekene Vest HF   (Norway)

Author keywords

Antidepressant; Anxiety disorders; Co morbidity; Depression; Epidemiology; Medication; Migraine

Indexed keywords

ALMOTRIPTAN; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DULOXETINE; ELETRIPTAN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NARATRIPTAN; NORTRIPTYLINE; PAROXETINE; REBOXETINE; RIZATRIPTAN; SERTRALINE; SUMATRIPTAN; TRIMIPRAMINE; VENLAFAXINE; ZOLMITRIPTAN;

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NORWAY; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; CHILD; COMORBIDITY; CONFIDENCE INTERVALS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NORWAY; ODDS RATIO; PREVALENCE; SEX FACTORS; YOUNG ADULT;

EID: 79851508772     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.09.009     Document Type: Article

References (43)

1. J. Alonso, M.C. Angermeyer, S. Bernert, R. Bruffaerts, T.S. Brugha, H. Bryson, G. de Girolamo, R. Graaf, K. Demyttenaere, I. Gasquet, J.M. Haro, S.J. Katz, R.C. Kessler, V. Kovess, J.P. Lepine, J. Ormel, G. Polidori, L.J. Russo, G. Vilagut, J. Almansa, S. Arbabzadeh-Bouchez, J. Autonell, M. Bernal, M.A. Buist-Bouwman, M. Codony, A. Domingo-Salvany, M. Ferrer, S.S. Joo, M. Martinez-Alonso, H. Matschinger, F. Mazzi, Z. Morgan, P. Morosini, C. Palacin, B. Romera, N. Taub, and W.A. Vollebergh Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project Acta Psychiatr. Scand. Suppl. 2004 21 27
2. M.E. Bigal, and R.B. Lipton The epidemiology, burden, and comorbidities of migraine Neurol. Clin. 27 2009 321 334
3. P. Blier, and R. Bergeron The safety of concomitant use of sumatriptan and antidepressant treatments J. Clin. Psychopharmacol. 15 1995 106 109
4. N. Breslau Psychiatric comorbidity in migraine Cephalalgia 18 Suppl 22 1998 56 58 discussion 58-61
5. N. Breslau, G.C. Davis, and P. Andreski Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults Psychiatry Res. 37 1991 11 23
6. N. Breslau, K. Merikangas, and C.L. Bowden Comorbidity of migraine and major affective disorders Neurology 44 1994 S17 S22
7. N. Breslau, L.R. Schultz, W.F. Stewart, R.B. Lipton, V.C. Lucia, and K.M. Welch Headache and major depression: is the association specific to migraine? Neurology 54 2000 308 313 (Pubitemid 30078058)
8. N. Breslau, R.B. Lipton, W.F. Stewart, L.R. Schultz, and K.M. Welch Comorbidity of migraine and depression: investigating potential etiology and prognosis Neurology 60 2003 1308 1312 (Pubitemid 36460987)
9. A. Charles Advances in the basic and clinical science of migraine Ann. Neurol. 65 2009 491 498
10. J.A. Cramer, and R. Rosenheck Compliance with medication regimens for mental and physical disorders Psychiatr. Serv. 49 1998 196 201 (Pubitemid 28071427)
11. C. Dahlof, and M. Linde One-year prevalence of migraine in Sweden: a population-based study in adults Cephalalgia 21 2001 664 671 (Pubitemid 32762789)
12. Davidoff Migraine: Manifestations, Pathogenesis, and Management 2002 Oxford University Press New York
13. K. Demyttenaere, P. Enzlin, W. Dewe, B. Boulanger, J. De Bie, W. De Troyer, and P. Mesters Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events J. Clin. Psychiatry 62 Suppl 22 2001 30 33 (Pubitemid 32937583)
14. S.C. Dilsaver, F. Benazzi, K.J. Oedegaard, O.B. Fasmer, and H.S. Akiskal Migraine in affectively ill Mexicans adolescents World Psychiatry 8 2009 37 39
15. S.C. Dilsaver, F. Benazzi, K.J. Oedegaard, O.B. Fasmer, K.K. Akiskal, and H.S. Akiskal Migraine headache in affectively ill Latino adults of Mexican American origin is associated with bipolarity Prim Care Companion J Clinical Psychiatry 11 2009 302 306
16. O.B. Fasmer, H.S. Akiskal, J.R. Kelsoe, and K.J. Oedegaard Clinical and pathophysiological relations between migraine and mood disorders Curr. Psychiatr. Rev. 5 2009 93 109
17. M.P. Freeman, S.A. Freeman, and S.L. McElroy The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues J. Affect. Disord. 68 2002 1 23 (Pubitemid 34178547)
18. D.M. Gardner, and L.D. Lynd Sumatriptan contraindications and the serotonin syndrome Ann. Pharmacother. 32 1998 33 38 (Pubitemid 28087230)
19. B.A. Gaudiano, L.M. Weinstock, and I.W. Miller Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development Behav. Modif. 32 2008 267 301
20. T. Hedenrud, P. Jonsson, and M. Linde Beliefs about medicines and adherence among Swedish migraineurs Ann. Pharmacother. 42 2008 39 45
21. N. Jette, S. Patten, J. Williams, W. Becker, and S. Wiebe Comorbidity of migraine and psychiatric disorders-a national population-based study Headache 48 2008 501 516 (Pubitemid 351464683)
22. C. Johannessen Landmark Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy CNS Drugs 22 2008 27 47 (Pubitemid 350243365)
23. H. Kececi, S. Dener, and E. Analan Co-morbidity of migraine and major depression in the Turkish population Cephalalgia 23 2003 271 275 (Pubitemid 36577944)
24. R.B. Lipton, and M.E. Bigal The epidemiology of migraine Am. J. Med. 118 Suppl 1 2005 3S 10S
25. J.L. Medina, and S. Diamond Cyclical migraine Arch. Neurol. 38 1981 343 344 (Pubitemid 11070202)
26. K.R. Merikangas, and D.E. Stevens Comorbidity of migraine and psychiatric disorders Neurol. Clin. 15 1997 115 123 (Pubitemid 27098703)
27. K.R. Merikangas, J. Angst, and H. Isler Migraine and psychopathology. Results of the Zurich cohort study of young adults Arch. Gen. Psychiatry 47 1990 849 853 (Pubitemid 20302700)
28. K.R. Merikangas, J.R. Merikangas, and J. Angst Headache syndromes and psychiatric disorders: association and familial transmission J. Psychiatr. Res. 27 1993 197 210 (Pubitemid 23234203)
29. K.R. Merikangas, D.E. Stevens, and J. Angst Psychopathology and headache syndromes in the community Headache 34 1994 S17 S22
30. D. Millson, M. Frischer, P. Croft, and P.J. Goadsby Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness? Cephalalgia 20 2000 732 737 (Pubitemid 32127842)
31. K.J. Oedegaard, D. Neckelmann, A. Mykletun, A.A. Dahl, J.A. Zwart, K. Hagen, and O.B. Fasmer Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study Cephalalgia 26 2006 1 6
32. K.J. Oedegaard, T.A. Greenwood, A. Lunde, O.B. Fasmer, H.S. Akiskal, and J.R. Kelsoe A genome-wide linkage study of bipolar disorder and co-morbid migraine: replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11 J. Affect. Disord. 22 2010 14 26
33. R.C. Peatfield Lithium in migraine and cluster headache: a review J. R. Soc. Med. 74 1981 432 436 (Pubitemid 11089368)
34. F. Radat, and J. Swendsen Psychiatric comorbidity in migraine: a review Cephalalgia 25 2005 165 178 (Pubitemid 40321708)
35. Ramadan, N.M., Schultz, L.L., Gilkey, S.J., 1997. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 17 (2), 73-80. Review.PMID: 9137841. (Pubitemid 27167496)
36. S.D. Silberstein Comprehensive management of headache and depression Cephalalgia 18 Suppl 21 1998 50 55
37. S.D. Silberstein Migraine Lancet 363 2004 381 391 (Pubitemid 38169549)
38. T. Sprenger, and P.J. Goadsby Migraine pathogenesis and state of pharmacological treatment options BMC Med. 7 2009 71
39. E. Stordal, M. Bjartveit Kruger, N.H. Dahl, O. Kruger, A. Mykletun, and A.A. Dahl Depression in relation to age and gender in the general population: the Nord-Trondelag Health Study (HUNT) Acta Psychiatr. Scand. 104 2001 210 216 (Pubitemid 32762275)
40. T.W. Strine, A.H. Mokdad, L.S. Balluz, O. Gonzalez, R. Crider, J.T. Berry, and K. Kroenke Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System Psychiatr. Serv. 59 2008 1383 1390
41. K.L. Swartz, L.A. Pratt, H.K. Armenian, L.C. Lee, and W.W. Eaton Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment area follow-up study Arch. Gen. Psychiatry 57 2000 945 950
42. H.G. Westenberg Recent advances in understanding and treating social anxiety disorder CNS Spectr. 14 2009 24 33
43. J.A. Zwart, G. Dyb, K. Hagen, K.J. Odegard, A.A. Dahl, G. Bovim, and L.J. Stovner Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study Eur. J. Neurol. 10 2003 147 152 (Pubitemid 36308208)